查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591984

免疫沉澱市場：依產品類型、最終用戶分類 - 2025-2030 年全球預測

Immunoprecipitation Market by Product (Accessories, Beads, Kits), Type (Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年免疫沉澱市場價值為13.6億美元，預計2024年將達16.4億美元，複合年成長率為20.78%，預計到2030年將達到51.3億美元。

免疫沉澱 (IP) 是分子生物學中的一項重要技術，用於利用抗體-抗原相互作用從混合物中分離特定抗原。它的價值在於其精製蛋白質和核酸的能力，這對於蛋白質表現分析、基因表現研究和轉譯後修飾研究等應用至關重要。該過程在製藥和生物技術等不同領域至關重要，並且在藥物開發和診斷研究中很有用。市場成長的推動因素包括研發投資的增加、蛋白質體學的進步以及需要在微妙的分子層面上進行洞察的慢性疾病數量的增加。開發自動化系統並生產更有效率、高性能的抗體可以加快常規實驗程序並提高精度。公司可以透過投資合作研究、專注於個人化醫療以及針對新興市場提供創新且具有成本效益的解決方案來利用這些機會。然而，這個市場面臨一些限制，例如與試劑和抗體相關的高成本、對熟練人員的需求以及維持複雜生物樣本的特異性和產量的挑戰。由於該細分市場對技術發展高度敏感，創新應專注於提高抗體特異性、改進精製技術以及整合人工智慧和機器學習以最佳化資料分析和預測建模。非侵入性採樣技術和新型生物標記的研究也可能釋放新的可能性。儘管市場競爭激烈，但開拓的時機已經成熟，趨勢以將 IP 與質譜和次世代定序等互補技術相結合的整合解決方案為中心。企業應保持敏捷性，跟上技術和監管變化的步伐，同時培養與學術機構和高科技公司的夥伴關係，以推動突破性創新。解決當前自動化和可重複性方面的差距對於持續成長和保持競爭優勢至關重要。

主要市場統計
基準年[2023] 13.6億美元
預計年份 [2024] 16.4億美元
預測年份 [2030] 51.3億美元
複合年成長率（%） 20.78%

市場動態：揭示快速發展的免疫沉澱市場的關鍵市場洞察

供需的動態交互作用正在改變免疫沉澱市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大免疫沉澱試驗在中樞神經系統疾病的應用
    • 生命科學實驗和研究活動增加
    • 改良染色質免疫通訊協定的開發
  • 市場限制因素
    • 蛋白質精製替代技術的存在
  • 市場機會
    • 免疫沉澱技術的進展
    • 政府及各行業加大投入
  • 市場問題
    • 研究抗體品質問題

波特五力：駕馭免疫沉澱市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解免疫沉澱市場的外部影響

外部宏觀環境因素在塑造免疫沉澱市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解免疫沉澱市場的競爭格局

對免疫沉澱市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：免疫沉澱市場供應商績效評估

FPNV定位矩陣是評估免疫沉澱市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃免疫沉澱市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，免疫沉澱市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大免疫沉澱試驗在中樞神經系統疾病的應用
      • 生命科學實驗和研究活動增加
      • 改良染色質免疫通訊協定的開發
    • 抑制因素
      • 蛋白質精製替代技術的存在
    • 機會
      • 免疫沉澱技術的進展
      • 政府及各行業加大投入
    • 任務
      • 研究抗體品質問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章免疫沉澱市場：依產品

  • 介紹
  • 配件
    • 一抗
    • 二抗
  • 珠
    • 瓊脂糖珠
    • 緩衝
    • 磁珠
  • 套件
  • 試劑

第7章免疫沉澱市場：依類型

  • 介紹
  • 染色質免疫沉澱
  • 免疫共沉澱
  • 個體免疫沉澱
  • RNA免疫沉澱

第8章免疫沉澱市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 合約研究組織
  • 製藥和生物技術公司

第9章美洲免疫沉澱市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太免疫沉澱市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲免疫沉澱市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbkine Scientific Co., Ltd
  • Abcam PLC
  • Axil Scientific Pte Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioLegend, Inc. by PerkinElmer Inc.
  • Cell Signaling Technology, Inc.
  • Creative Biomart Inc.
  • Cytoskeleton, Inc.
  • EpiGentek Group Inc.
  • Geno Technology, Inc.
  • LifeSpan BioSciences, Inc.
  • MyJoVE Corporation
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-43676CF42C5B

The Immunoprecipitation Market was valued at USD 1.36 billion in 2023, expected to reach USD 1.64 billion in 2024, and is projected to grow at a CAGR of 20.78%, to USD 5.13 billion by 2030.

Immunoprecipitation (IP) is a key technique in molecular biology used to isolate a specific antigen from a mixture, utilizing an antibody-antigen interaction. Its value lies in its ability to purify proteins or nucleic acids, making it essential for applications such as protein expression analysis, gene expression studies, and post-translational modification investigations. The procedure is pivotal across diverse sectors like pharmaceuticals and biotechnology, where it aids in drug development and diagnostic research. Market growth is fueled by increasing R&D investments, advancements in proteomics, and the rising prevalence of chronic diseases requiring nuanced molecular insights. Opportunities abound in developing automated systems and creating more efficient, high-throughput antibodies, which can expedite routine lab procedures and enhance accuracy. Companies can harness these opportunities by investing in collaborative research, focusing on personalized medicine, and targeting emerging markets with innovative, cost-effective solutions. However, the market faces limitations such as high costs associated with reagents and antibodies, a requirement for skilled personnel, and challenges in maintaining specificity and yield in complex biological samples. As the sector is highly sensitive to technical developments, innovation should focus on enhancing antibody specificity, refining purification techniques, and integrating AI and machine learning to optimize data analysis and predictive modeling. Research into non-invasive sampling techniques and novel biomarkers could also unlock new potentials. The immunoprecipitation market is competitive but ripe for exploration, with trends pointing towards integrated solutions that combine IP with complementary technologies like mass spectrometry and next-generation sequencing. Businesses should remain agile, staying abreast of technological and regulatory changes, while fostering partnerships with academic institutions and tech companies to drive groundbreaking innovations. Addressing the current gaps in automation and reproducibility will be critical for sustained growth and maintaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 1.36 billion
Estimated Year [2024] USD 1.64 billion
Forecast Year [2030] USD 5.13 billion
CAGR (%) 20.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprecipitation Market

The Immunoprecipitation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing applications of immunoprecipitation testing in central nervous disorders
    • Rise in the number of life science experiments and research activities
    • Development of improved protocols for chromatin immunoprecipitation
  • Market Restraints
    • Presence of alternative technologies for protein purification
  • Market Opportunities
    • Advancements in immunoprecipitation techniques
    • Rising investments by governments and various industries
  • Market Challenges
    • Issues related to quality over research antibodies

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprecipitation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprecipitation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprecipitation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprecipitation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprecipitation Market

A detailed market share analysis in the Immunoprecipitation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprecipitation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprecipitation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprecipitation Market

A strategic analysis of the Immunoprecipitation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprecipitation Market, highlighting leading vendors and their innovative profiles. These include Abbkine Scientific Co., Ltd, Abcam PLC, Axil Scientific Pte Ltd., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer Inc., Cell Signaling Technology, Inc., Creative Biomart Inc., Cytoskeleton, Inc., EpiGentek Group Inc., Geno Technology, Inc., LifeSpan BioSciences, Inc., MyJoVE Corporation, Proteintech Group, Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Immunoprecipitation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Beads, Kits, and Reagents. The Accessories is further studied across Primary Antibodies and Secondary Antibodies. The Beads is further studied across Agarose Beads, Buffers, and Magnetic Beads.
  • Based on Type, market is studied across Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation, and RNA Immunoprecipitation.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing applications of immunoprecipitation testing in central nervous disorders
      • 5.1.1.2. Rise in the number of life science experiments and research activities
      • 5.1.1.3. Development of improved protocols for chromatin immunoprecipitation
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of alternative technologies for protein purification
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in immunoprecipitation techniques
      • 5.1.3.2. Rising investments by governments and various industries
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to quality over research antibodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoprecipitation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Primary Antibodies
    • 6.2.2. Secondary Antibodies
  • 6.3. Beads
    • 6.3.1. Agarose Beads
    • 6.3.2. Buffers
    • 6.3.3. Magnetic Beads
  • 6.4. Kits
  • 6.5. Reagents

7. Immunoprecipitation Market, by Type

  • 7.1. Introduction
  • 7.2. Chromatin Immunoprecipitation
  • 7.3. Co-Immunoprecipitation
  • 7.4. Individual Immunoprecipitation
  • 7.5. RNA Immunoprecipitation

8. Immunoprecipitation Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Immunoprecipitation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoprecipitation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprecipitation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbkine Scientific Co., Ltd
  • 2. Abcam PLC
  • 3. Axil Scientific Pte Ltd.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioLegend, Inc. by PerkinElmer Inc.
  • 6. Cell Signaling Technology, Inc.
  • 7. Creative Biomart Inc.
  • 8. Cytoskeleton, Inc.
  • 9. EpiGentek Group Inc.
  • 10. Geno Technology, Inc.
  • 11. LifeSpan BioSciences, Inc.
  • 12. MyJoVE Corporation
  • 13. Proteintech Group, Inc.
  • 14. Sino Biological Inc.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPRECIPITATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOPRECIPITATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPRECIPITATION MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CHROMATIN IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CO-IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY INDIVIDUAL IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RNA IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023